Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-10-15
pubmed:abstractText
The aim of this study was to screen for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala Koidz. The rhizomes of Atractylodes macrocephala were treated with supercritical CO(2) fluid and the extract was separated by normal-phase and reverse-phase column chromatography. The separated samples were screened with white blood cell membrane (WBCM) chromatography (WBCM-C). The anti-inflammatory effects of these fractions and components were tested pharmacologically in vivo. The results indicated that the retention characteristics of the petrol-ether (1:1, v/v) fraction (BZC-2) of the supercritical CO(2) extract, the atractylenolide I and 14-acetoxy-12-senecioyloxytetradeca-2E,8E,10E-trien-4, 6-diyn-1-ol isolated from BZC-2 as active fractions and components were similar to that of dexamethasone in WBCM-C. Therefore, they may act on WBCM and its receptors. BZC-2 has shown anti-inflammatory effects in acute and chronic inflammation models in rats and mice. Oral administration of atractylenolide I and 14-acetoxy-12-senecioyloxytetradeca-2E,8E,10E-trien-4,6-diyn-1-ol produced significant anti-inflammatory effects in acute and chronic inflammation models in mice. The screening results with WBCM-C were correlated significantly with pharmacological effects in vivo. Atractylenolide I and 14-acetoxy-12-senecioyloxytetradeca-2E,8E,10E-trien-4,6-diyn-1-ol were the main components of Atractylodes macrocephala that were effective as anti-inflammatory agents.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0378-8741
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
212-7
pubmed:meshHeading
pubmed-meshheading:17869038-Acetic Acid, pubmed-meshheading:17869038-Animals, pubmed-meshheading:17869038-Anti-Inflammatory Agents, pubmed-meshheading:17869038-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:17869038-Atractylodes, pubmed-meshheading:17869038-Capillary Permeability, pubmed-meshheading:17869038-Carrageenan, pubmed-meshheading:17869038-Cell Membrane, pubmed-meshheading:17869038-Chromatography, pubmed-meshheading:17869038-Cotton Fiber, pubmed-meshheading:17869038-Dexamethasone, pubmed-meshheading:17869038-Drug Evaluation, Preclinical, pubmed-meshheading:17869038-Edema, pubmed-meshheading:17869038-Female, pubmed-meshheading:17869038-Granuloma, pubmed-meshheading:17869038-Leukocytes, pubmed-meshheading:17869038-Magnetic Resonance Spectroscopy, pubmed-meshheading:17869038-Male, pubmed-meshheading:17869038-Plant Extracts, pubmed-meshheading:17869038-Plant Roots, pubmed-meshheading:17869038-Rabbits
pubmed:year
2007
pubmed:articleTitle
Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz.
pubmed:affiliation
School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China.
pubmed:publicationType
Journal Article